Meglutol

CAS No. 503-49-1

Meglutol( Meglutol | HMGA | NSC 361411 | NSC-361411 | NSC361411 )

Catalog No. M14708 CAS No. 503-49-1

MEGLUTOL is an antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 41 In Stock
100MG 67 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Meglutol
  • Note
    Research use only, not for human use.
  • Brief Description
    MEGLUTOL is an antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids.
  • Description
    Meglutol is an antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids, and inhibits the activity of hydroxymethylglutarryl CoA reductases, which is the rate limiting enzyme in the biosynthesis of cholesterol.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Meglutol | HMGA | NSC 361411 | NSC-361411 | NSC361411
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    HMGCR
  • Recptor
    HMG-CoA reductase
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    503-49-1
  • Formula Weight
    162.14
  • Molecular Formula
    C6H10O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    O=C(O)CC(C)(O)CC(O)=O
  • Chemical Name
    3-hydroxy-3-methylpentanedioic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Santarelli F, et al. Ital J Pediatr. 2013 May 24;39:33.
molnova catalog
related products
  • Clinofibrate

    Clinofibrate inhibits hydroxymethylglutaryl coenzyme A reductase (HMGCR) with IC50 of 0.47 mM.

  • Monacolin J

    Monacolin J is a cholesterol biosynthesis inhibitor.

  • Apomine

    Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and has been implicated in the regulation of myeloma in vivo. Apomine accelerates the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase and stimulates low-density lipoprotein receptor activity.